Shire says AbbVie should not renege on merger deal
October 15, 2014 at 02:13 AM EDT
LONDON, Oct 15 (Reuters) - London-listed pharmaceutical firm Shire plc said it believed AbbVie should proceed with its $54.7 billion takeover after AbbVie on Tuesday said it could reconsider its support for the deal.
